Colorectal Cancer

“…Diagnosis treatment and research. With the resources of Roswell Park Cancer Institute a comprehensive cancer treatment and research facility in Buffalo, New York. I'm Tim Wenger and this week cancer and genetics with some …”

“…grow out of control and in some ways that's the basis for cancer. . Cells that don't behave themselves. Because in most cases there are some genetic changes within the cell that don't allowed to function properly …”

“…to Tamoxifen works is it it basically. Inhibits. Aid for thirteen on breast cancer cells or breast cells called the estrogen receptor. And estrogen receptor is responsible for cells growing in dividing and so when you give the woman Tamoxifen. At least what we know now about the way Tamoxifen. Works and doctor -- may have it another mechanism. Is we know that Tamoxifen binds this -- interceptor and prevents estrogen from binding and their for a week. Are slowing down growth itself doesn't work for every breast cancer patient knowing it it doesn't work for every breast cancer patients and and that's one of the things that we wanna find out with the study. And we're where you've seen success with with Tamoxifen any particular. On type of or stage of breast cancer patient and that's actually the great things about Tamoxifen and it is useful in all stages of breast cancer it's it's particularly in estrogen receptor positive went. They can be used to prevent breast cancer in women who don't have breast cancer yet it can be used in. Very early stage disease is in DC I answered noninvasive breast cancer. . And then they can be used in in early stage invasive breast cancer all the way to metastatic disease that can be used in the metastatic settings well. …”

“…Tim Wenger and this week we go very in depth on a breast cancer related study on Tamoxifen treatment. A full studio today and I we've got a familiar face and voice with us doctors what he called -- doctor -- Ernie welcome back to the microphone. Pre you're geared to becoming a regular radio pro four. Tactical Carney is a position in breast surgery at Roswell and director of the breast cancer risk assessment. And prevention program and and we'll start with the doctor -- in just a moment she's brought along. A clan of …”

“…And research. With the vast resources of Roswell Park Cancer Institute a truly comprehensive cancer treatment and research facility in Buffalo, New York. I'm Tim Wenger and this week colorectal cancer some insight treatment and we'll talk about outcomes as well. With me today is doctor Kelly -- Dunn associate professor of surgery at Roswell Park Cancer Institute. . And doctor thank you for being here you've been here before thank you for having me back I'm sure you'll be here again. Thank you so much and you brought along today -- Garcia. Vicky working and the Department of Human Services at Roswell new resources and human resources okay and serie and you also and we'll hear your story or current patients at Russell -- some pretty unique story. That we will get to let's start with the good doctor though. Colorectal cancer. . We it seems to me here more and more about it. You know most recently in other. High profile television personality had to call and ask the NTV and that's a good thing because. You know it it raises awareness but it does seem that we're talking more and more about colorectal cancer how common is it. …”

“…United States and and this. Cancer is the third leading cause of cancer death in both men and women so it's quite common. Any given individual has a -- one in eleven chance of having colorectal cancer at some point during their lifetime so it's it's one of the most common diseases that we say. …”